Targeted Testing For Immuno Oncology

Immuno Oncology therapies offer some of the most promising and effective options for cancer treatment, and are revolutionizing the way we think about oncology practice. Because not all patients will respond to these therapies, accurate testing methodologies are critical. This webinar will review the current options for testing tumor samples for sensitivity to current Immuno Oncology agents, with the aim of empowering pathologists to effectively participate in this important type of clinical testing.

Presenter:

Anna B. Berry, MD, FCAP